APA (7th ed.) Citation

TH, L., H, L., JY, J., W, P., WK, C., EY, C., . . . H, K. (2026). Refined risk stratification in residual triple-negative breast cancer after neoadjuvant therapy using residual cancer burden class and lymphovascular invasion. Breast cancer research and treatment, 215(3), 76. https://doi.org/10.1007/s10549-026-07906-8

Chicago Style (17th ed.) Citation

TH, Lee, et al. "Refined Risk Stratification in Residual Triple-negative Breast Cancer After Neoadjuvant Therapy Using Residual Cancer Burden Class and Lymphovascular Invasion." Breast Cancer Research and Treatment 215, no. 3 (2026): 76. https://doi.org/10.1007/s10549-026-07906-8.

MLA (9th ed.) Citation

TH, Lee, et al. "Refined Risk Stratification in Residual Triple-negative Breast Cancer After Neoadjuvant Therapy Using Residual Cancer Burden Class and Lymphovascular Invasion." Breast Cancer Research and Treatment, vol. 215, no. 3, 2026, p. 76, https://doi.org/10.1007/s10549-026-07906-8.